Yüklüyor......

New targets for therapy in breast cancer: Small molecule tyrosine kinase inhibitors

Over the past several years many advances have been made in our understanding of critical pathways involved in carcinogenesis and tumor growth. These advances have led to the investigation of small molecule inhibitors of the ErbB family of receptor tyrosine kinases across a broad spectrum of maligna...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Lin, Nancy U, Winer, Eric P
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2004
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC549180/
https://ncbi.nlm.nih.gov/pubmed/15318926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr919
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!